Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalia Rotstein

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Multiple Sclerosis and Related Disorders|February 4, 2026
Incident and prevalent peripartum mental illness in mothers with multiple sclerosis and other chronic diseases in SwedenRuth Ann Marrie, Colleen J Maxwell, James M Bolton, et al.
Multiple Sclerosis and Related Disorders|January 14, 2022
Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, CanadaJacqueline M Solomon, Ashley Jones, Marika Hohol, et al.
Neurology|January 22, 2025
Peripartum Mental Illness in Mothers With Multiple Sclerosis and Other Chronic Diseases in Ontario, CanadaRuth Ann Marrie, James Bolton, Yushu Vicki Ling, et al.
Research Square|December 11, 2023
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodiesMiyo K Chatanaka, Lisa M Avery, Maria D Pasic, et al.
Clinical Proteomics|April 5, 2024
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodiesMiyo K Chatanaka, Lisa M Avery, Maria D Pasic, et al.
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and AustralasiaLilyana Amezcua, Dalia Rotstein, Afsaneh Shirani, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and SatralizumabFriedemann Paul, Romain Marignier, Jacqueline Palace, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Multiple Sclerosis and Related Disorders|February 4, 2026
Incident and prevalent peripartum mental illness in mothers with multiple sclerosis and other chronic diseases in SwedenRuth Ann Marrie, Colleen J Maxwell, James M Bolton, et al.
Multiple Sclerosis and Related Disorders|January 14, 2022
Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, CanadaJacqueline M Solomon, Ashley Jones, Marika Hohol, et al.
Neurology|January 22, 2025
Peripartum Mental Illness in Mothers With Multiple Sclerosis and Other Chronic Diseases in Ontario, CanadaRuth Ann Marrie, James Bolton, Yushu Vicki Ling, et al.
Research Square|December 11, 2023
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodiesMiyo K Chatanaka, Lisa M Avery, Maria D Pasic, et al.
Clinical Proteomics|April 5, 2024
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodiesMiyo K Chatanaka, Lisa M Avery, Maria D Pasic, et al.
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and AustralasiaLilyana Amezcua, Dalia Rotstein, Afsaneh Shirani, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and SatralizumabFriedemann Paul, Romain Marignier, Jacqueline Palace, et al.
Pageof 3